Prime Discoveries develops rapid, novel diagnostics for emerging pathogen infections with a focus on cost effective, massively scalable and easily automatable assays. Prime leverages multiple patented advanced technologies in microbial diagnostics including RT-LAMP, Rapid PCR, and mNGS (Next generation sequencing) to enable samples to result in under 1 hour with minimal lab infrastructure and technical expertise.
Prime’s products are best in class for Covid, Influenza, Sexually Transmitted Infections and new drug resistant microbes. All of Prime’s assays are locally developed in the United States and can serve millions of people.
Founded in NYC in 2017, Prime’s scientists have extensive backgrounds in microbiology, computational biology, lab automation and AI from Genentech, Cooper Genomics, Recombine, Phosphorus, and NYU. Prime is advised by leading experts in the fields of genomics and public health including Dr. George Church and Esther Dyson.
Prime is supported by academic institutions, venture capital firms and angel investors including New York University, Charles Zegar, BoxGroup, Akron Fusion Ventures, Beresford Ventures, Cannonball Capital, Liquid 2 Ventures, Francois Nader (Moderna, Acceleron, Shire), Unshackled Ventures, Doberman Forward, and others.
Prime’s products are best in class for Covid, Influenza, Sexually Transmitted Infections and new drug resistant microbes. All of Prime’s assays are locally developed in the United States and can serve millions of people.
Founded in NYC in 2017, Prime’s scientists have extensive backgrounds in microbiology, computational biology, lab automation and AI from Genentech, Cooper Genomics, Recombine, Phosphorus, and NYU. Prime is advised by leading experts in the fields of genomics and public health including Dr. George Church and Esther Dyson.
Prime is supported by academic institutions, venture capital firms and angel investors including New York University, Charles Zegar, BoxGroup, Akron Fusion Ventures, Beresford Ventures, Cannonball Capital, Liquid 2 Ventures, Francois Nader (Moderna, Acceleron, Shire), Unshackled Ventures, Doberman Forward, and others.
Location: United States, New York
Founded date: 2018
Investors 5
| Date | Name | Website |
| - | Interstate... | interstate... |
| - | Creative D... | creativede... |
| - | BoxGroup | boxgroup.c... |
| 09.12.2020 | Future Lab... | futurelabs... |
| - | Broad Stre... | broadstree... |
Mentions in press and media 1
| Date | Title | Description |
| 16.12.2021 | Prime Discoveries, a New York Microbiome Startup, Launches Rapid Microbe Panels for Screening COVID-19, Candida Auris, Sexually Transmitted Infections and Respiratory infections | Prime Discoveries, Inc, (“Prime”) develops rapid novel microbe panels for emerging pathogen infections in the areas of infectious diseases, reproductive health, and oncology for laboratories that are cost effective, massively scalable and e... |